Prelude Therapeutics Incorporated Share Price
NASDAQ: PRLDHealthcare
Live Prelude Therapeutics Incorporated Share Price Chart
O H L
Prelude Therapeutics Incorporated Performance Overview
Days Range
▼
$4.59Low
$4.74High
Markets Today
| Previous Close | $4.57 |
|---|---|
| Open | $4.59 |
| Volume | 138,713 |
| Day's Range | $4.59 - $4.74 |
| 52W Range | $0.98 - $6.83 |
| Market Cap | $356.72 M |
Historical Performance
| 1M Returns | -20.52 |
|---|---|
| 3M Returns | +5.79 |
| 6M Returns | +46.47 |
| 1Y Returns | +352.48 |
| 5Y Returns | -87.02 |
| 10Y Returns | NA |
Prelude Therapeutics Incorporated Fundamentals
| Market Cap | $356.72 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $12.14 M |
| ROE TTM | -0.99 |
| EPS TTM | $-0.73 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.67 |
| EBITDA | $-102.86 M |
| Profit Margin | -819.59 |
| Market Cap | $356.72 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $12.14 M |
| ROE TTM | -0.99 |
| EPS TTM | $-0.73 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.67 |
| EBITDA | $-102.86 M |
| Profit Margin | -819.59 |
Prelude Therapeutics Incorporated Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $6.50 M | $5.64 M | $4.58 M | $5.70 M |
| Gross Profit + | $0 | $0 | $6.50 M | $5.64 M | $4.58 M | $5.70 M |
| Operating Income | -$34.61 M | -$32.19 M | -$20.42 M | -$17.35 M | -$14.18 M | -$15.45 M |
| EBITDA | -$34.17 M | -$31.76 M | -$19.99 M | -$16.93 M | -$13.79 M | -$15.10 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $435.00 K | $433.00 K | $425.00 K | $418.00 K | $391.00 K | $353.00 K |
| Income Before Tax | -$32.09 M | -$31.23 M | -$19.73 M | -$16.46 M | -$10.38 M | -$13.92 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$32.09 M | -$31.23 M | -$19.73 M | -$16.46 M | -$10.38 M | -$13.92 M |
| Net Profit Margin | - | - | -303.46% | -291.79% | -226.75% | -244.06% |
Prelude Therapeutics Incorporated Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $5.00 K | $5.00 K | $5.00 K | $6.00 K | $6.00 K | $8.00 K |
| Reserve & Surplus | -$615.64 M | -$646.88 M | -$666.60 M | -$683.05 M | -$693.49 M | -$707.59 M |
| Non-Current Liabilities | $18.30 M | $18.17 M | $18.03 M | $19.68 M | $17.74 M | $17.59 M |
| Current Liabilities | $19.79 M | $20.91 M | $18.19 M | $52.99 M | $41.72 M | $38.04 M |
| Total Liabilities | $38.08 M | $39.08 M | $36.22 M | $72.68 M | $59.46 M | $55.63 M |
| Fixed Assets | $6.39 M | $5.96 M | $5.53 M | $5.11 M | $4.72 M | $4.40 M |
| Current Assets | $102.40 M | $76.88 M | $58.33 M | $105.69 M | $84.59 M | $154.90 M |
| Total Assets | $141.26 M | $114.92 M | $94.75 M | $141.31 M | $119.64 M | $189.36 M |
Prelude Therapeutics Incorporated Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$32.09 M | -$31.23 M | -$19.73 M | -$16.46 M | -$10.38 M | -$13.92 M |
| Operating Cash Flow | -$34.23 M | -$26.07 M | -$19.11 M | $23.12 M | -$21.68 M | -$15.57 M |
| Investing Cash Flow | $62.19 M | $11.52 M | $40.09 M | -$60.34 M | $8.50 M | -$65.50 M |
| Financing Cash Flow | -$160.00 K | $37.00 K | -$5.00 K | $24.94 M | -$314.00 K | $85.82 M |
| Change in Cash | $27.80 M | -$14.52 M | $20.97 M | -$12.28 M | -$13.50 M | $4.74 M |
Prelude Therapeutics Incorporated Return Calculator
The Prelude Therapeutics Incorporated stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,341
Invested Amount$10,000
Est. Returns$-8,659
About Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
Popular Stocks
FAQs
What is the share price of Prelude Therapeutics Incorporated today?
Prelude Therapeutics Incorporated (PRLD) share price as of September 18, 2026 is $4.72. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Prelude Therapeutics Incorporated?
Yes, Indian Investors can invest in the Prelude Therapeutics Incorporated (PRLD) Share by opening an international trading account with Angel One.
How can I purchase Prelude Therapeutics Incorporated shares in India?
Purchasing Prelude Therapeutics Incorporated (PRLD) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Prelude Therapeutics Incorporated (PRLD) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Prelude Therapeutics Incorporated?
Yes, you can purchase fractional shares of Prelude Therapeutics Incorporated (PRLD) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Prelude Therapeutics Incorporated?
The market capitalization of Prelude Therapeutics Incorporated on September 18, 2026, is $356.72 M.
In which sector Prelude Therapeutics Incorporated belongs?
Prelude Therapeutics Incorporated operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Prelude Therapeutics Incorporated stocks?
In order to invest in Prelude Therapeutics Incorporated (PRLD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
